US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

270.23

-8.7920-3.15%

Volume:157.33K

Turnover:42.16M

Market Cap:506.54M

PE:- -

High:274.71

Open:265.00

Low:260.01

Close:279.02

52wk High:341.93

52wk Low:74.95

Shares:1.87M

Float Shares:1.87M

Volume Ratio:2.30

T/O Rate:8.39%

Dividend:1.00

Dividend Rate:0.37%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Health Care Roundup: Market Talk

HCA Healthcare Delivers Consistent Message Around H2 Cadence Expectations, RBC Says

MT Newswires Live

RedHill Biopharma Pushes for Growth Securing Rights to Ferring’s $37M Gastrointestinal Drugs Portfolio

Analysts Offer Insights on Healthcare Companies: Establishment Labs Holdings (ESTA) and MiMedx Group (MDXG)

Akari Therapeutics Selected to Showcase Novel PH1 ADC Payload Platform at Leading Global Oncology, ADC and Healthcare Forums

Surrozen submits investigational new drug application for SZN-8141

Quoin Pharmaceuticals granted Rare Pediatric Disease Designation for QRX003

Sector Update: Healthcare

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Guardant Health (GH) and Neurocrine (NBIX)

Concord Healthcare Controlling Shareholder Revises H-Share Pledge for Smaller Loan

Definium Therapeutics Gains FDA Breakthrough for Depression Drug

CRISPR Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

Intellia Therapeutics announces FDA acceptance of lonvo-z BLA

Alebund Wins FDA IND Clearance for First-in-Class IgA Nephropathy Drug AP308

NovaBridge Biosciences Strengthens Board with Appointment of Veteran Healthcare Executive

Definium Therapeutics receives Breakthrough Therapy designation for DT120 ODT

Atea Pharmaceuticals to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

X4 Pharmaceuticals Announces Positive Outcome from FDA Type C Meeting

Analysts Offer Insights on Healthcare Companies: Dyne Therapeutics (DYN), NewAmsterdam Pharma Company (NAMS) and Ionis Pharmaceuticals (IONS)

Apitegromab’s Expanding FSHD Opportunity Supports Buy Rating; $65 Price Target Maintained

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/LABU/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":270.228,"timestamp":1789052152078,"preClose":279.02,"halted":0,"volume":157327,"delay":0,"changeRate":-0.03151028600100342,"floatShares":1874486,"shares":1874486,"eps":0,"marketStatus":"Trading","change":-8.792,"latestTime":"09-10 10:56:10 EDT","open":265,"high":274.705,"low":260.01,"amount":42163966.3867,"amplitude":0.052666,"askPrice":270,"askSize":130,"bidPrice":269,"bidSize":1,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789070400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":279.02,"sharesOutstanding":3074486,"nav":292.443,"aum":548181239.8,"dividendRate":0.003717,"bidAskSpread":0.003029,"preHourTrading":{"tag":"盘前","latestPrice":268.99,"preClose":279.02,"latestTime":"09:29 EDT","volume":1828,"amount":503835.0052,"timestamp":1789046962415,"change":-10.03,"changeRate":-0.035947,"amplitude":0.054249},"postHourTrading":{"tag":"盘后","latestPrice":278.58,"preClose":279.02,"latestTime":"19:59 EDT","volume":5408,"amount":1506106.6336,"timestamp":1788998373887,"change":-0.44,"changeRate":-0.001577,"amplitude":0.005304},"volumeRatio":2.295481,"impliedVol":0.9242,"impliedVolPercentile":0.5418},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1874486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.295481,"shares":1874486,"dividePrice":1.0045,"high":274.705,"amplitude":0.052666,"preClose":279.02,"low":260.01,"week52Low":74.95,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":270.228,"committee":-0.984733,"eps":0,"divideRate":0.003717,"volume":157327,"delay":0,"ttmEps":0,"open":265,"prevYearClose":159.39,"prevWeekClose":303.55,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":311.81,"twentyDayClose":286.75,"sixtyDayClose":188.53},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666371944","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2666371944","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666371944?lang=en_us&edition=fundamental","pubTime":"2026-09-09 00:20","pubTimestamp":1788884400,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0417 ET - Novartis's latest clinical-trial failure suggests the ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","XBI","XLV","LABU","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665737976","title":"HCA Healthcare Delivers Consistent Message Around H2 Cadence Expectations, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2665737976","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665737976?lang=en_us&edition=fundamental","pubTime":"2026-09-08 23:43","pubTimestamp":1788882197,"startTime":"0","endTime":"0","summary":"HCA Healthcare's (HCA) management delivered a consistent message around second-half cadence expectations, with a more difficult comparison ahead for Q3 and a relatively more favorable comparison for Q","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1084165304.USD","LU1150488218.USD","LU0068578508.USD","SG9999014021.USD","LU1119994496.HKD","LU1201861249.SGD","SG9999014005.SGD","LU0868494617.USD","BK4185","IE00B3S45H60.SGD","IHF","HCA","LABU","LU0878866978.SGD","LU1267930490.SGD","IE00B775SV38.USD","LU1267930573.SGD","LU2355687059.USD","SG9999014013.SGD","BK4504","BK4585","XLV","LU0211327993.USD","SG9999014039.USD","LU0310799852.SGD","LU0985489474.SGD","LU0187121727.USD","LU0708994859.HKD","LU1150488135.SGD","BK4588","LU1261432733.SGD","LU0648001328.SGD","LU0114720955.EUR","LU0882574055.USD","LU0211328371.USD","LU1489326972.SGD","LU0310800379.SGD","LU0130102774.USD","LU0433182093.SGD","LU0203345920.USD","BK4581","LU0029864427.USD","LU0203347892.USD","LU0128525929.USD","LU2244417387.USD","XBI","LU0980610538.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665793803","title":"RedHill Biopharma Pushes for Growth Securing Rights to Ferring’s $37M Gastrointestinal Drugs Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2665793803","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665793803?lang=en_us&edition=fundamental","pubTime":"2026-09-08 22:49","pubTimestamp":1788878982,"startTime":"0","endTime":"0","summary":"RedHill Biopharma ($RHDL) has said the acquisition from Ferring of commercialization rights to two established gastrointestinal (GI) FDA-approved d...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/redhill-biopharma-pushes-for-growth-securing-rights-to-ferrings-37m-gastrointestinal-drugs-portfolio?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/redhill-biopharma-pushes-for-growth-securing-rights-to-ferrings-37m-gastrointestinal-drugs-portfolio?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665375964","title":"Analysts Offer Insights on Healthcare Companies: Establishment Labs Holdings (ESTA) and MiMedx Group (MDXG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665375964","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665375964?lang=en_us&edition=fundamental","pubTime":"2026-09-08 21:20","pubTimestamp":1788873611,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Establishment Labs Holdings (ESTA) and MiMedx Group ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-establishment-labs-holdings-esta-and-mimedx-group-mdxg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-establishment-labs-holdings-esta-and-mimedx-group-mdxg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","LU2324357040.USD","ESTA","BK4588","MDXG","XBI","XLV","LABU","BK4139","LU0128526141.USD","BK4198","BK4137","BK4585","BK4581","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665013373","title":"Akari Therapeutics Selected to Showcase Novel PH1 ADC Payload Platform at Leading Global Oncology, ADC and Healthcare Forums","url":"https://stock-news.laohu8.com/highlight/detail?id=2665013373","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665013373?lang=en_us&edition=fundamental","pubTime":"2026-09-08 21:15","pubTimestamp":1788873300,"startTime":"0","endTime":"0","summary":"Company invited to present alongside global pharmaceutical, biotechnology and industry leaders at five high-profile U.S. and China conferences in September CEO Abizer Gaslightwala to deliver keynote a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/08/3357752/0/en/akari-therapeutics-selected-to-showcase-novel-ph1-adc-payload-platform-at-leading-global-oncology-adc-and-healthcare-forums.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","LENZ","BK4581","HCSG","XBI","XLV","BK4139","LABU","BK4588","LU0128526141.USD","BK4007","LU0029874061.USD","BK4585","BK4539","IEIH","BK4137","CST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665375834","title":"Surrozen submits investigational new drug application for SZN-8141","url":"https://stock-news.laohu8.com/highlight/detail?id=2665375834","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665375834?lang=en_us&edition=fundamental","pubTime":"2026-09-08 21:10","pubTimestamp":1788873057,"startTime":"0","endTime":"0","summary":"Surrozen (SRZN) announced the submission of an investigational new drug application to the FDA seeking to evaluate SZN-8141, a bifunctional Wnt ago...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/surrozen-submits-investigational-new-drug-application-for-szn-8141-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/surrozen-submits-investigational-new-drug-application-for-szn-8141-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4588","BK4585","LABU","SRZN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665537583","title":"Quoin Pharmaceuticals granted Rare Pediatric Disease Designation for QRX003","url":"https://stock-news.laohu8.com/highlight/detail?id=2665537583","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665537583?lang=en_us&edition=fundamental","pubTime":"2026-09-08 21:05","pubTimestamp":1788872727,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals (QNRX) announced that the FDA has granted Rare Pediatric Disease Designation for the company’s lead asset, QRX003, for the tr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-granted-rare-pediatric-disease-designation-for-qrx003-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-granted-rare-pediatric-disease-designation-for-qrx003-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LABU","BK4585","BK4588","QNRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665373903","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2665373903","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665373903?lang=en_us&edition=fundamental","pubTime":"2026-09-08 21:02","pubTimestamp":1788872523,"startTime":"0","endTime":"0","summary":"Financial stocks were flat to lower pre-bell Tuesday, with the iShares Biotechnology ETF  inactive and the State Street Health Care Select Sector SPDR ETF  declining by 1.3%.Novartis  stock was down more than 12% after the company said its late-stage study evaluating delpacibart etedesiran in patients with myotonic dystrophy type 1 has failed to meet its primary endpoint of video hand opening time.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4578","LABU","IE00B2B36J28.USD","LU0320765489.SGD","XLV","PPH","LU0029874061.USD","LU0208291251.USD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","LU0070302665.USD","LU0211331839.USD","LU0128526141.USD","BK4532","IBB","BK4581","HCSG","BK4137","MEDX","IE0002141913.USD","IE0009355771.USD","NVS","BK4585","BK4007","IE00BFTCPJ56.SGD","XBI","BK4588","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665373511","title":"Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Guardant Health (GH) and Neurocrine (NBIX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665373511","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665373511?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:51","pubTimestamp":1788871865,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Amgen (AMGN), Guardant Health (GH) and Neurocrine (N...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-guardant-health-gh-and-neurocrine-nbix-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-guardant-health-gh-and-neurocrine-nbix-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0823416689.USD","IE00BFTCPJ56.SGD","LU1061106388.HKD","LU0289739699.SGD","GNMX","AMGN","LU1057294990.SGD","LU2242646821.SGD","BK4137","PBE","LU0889565916.HKD","LU0109394709.USD","XLV","IE00BJT1NW94.SGD","BIB","BBH","NBIX","BK4588","LU0154245756.USD","XBI","BK4599","LU0058720904.USD","HELX","BK4534","LU2242652126.USD","GDOC","LU2468319806.SGD","LU0029874061.USD","IBB","PJP","PTH","BK4585","TBXU","BK4535","IE0002141913.USD","GH","HCSG","BK4139","LABU","FFOX","LFSC","IBBQ","BK4533","LU1571399168.USD","LU2065170008.USD","LU0154245673.USD","GNOM","EKG","IE0009355771.USD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665378258","title":"Concord Healthcare Controlling Shareholder Revises H-Share Pledge for Smaller Loan","url":"https://stock-news.laohu8.com/highlight/detail?id=2665378258","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665378258?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:37","pubTimestamp":1788871052,"startTime":"0","endTime":"0","summary":"Concord Healthcare Group Co., Ltd. Class H ( ($HK:2453) ) just unveiled an announcement. Concord Healthcare Group Co., Ltd. has disclosed that its ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/concord-healthcare-controlling-shareholder-revises-h-share-pledge-for-smaller-loan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/concord-healthcare-controlling-shareholder-revises-h-share-pledge-for-smaller-loan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4588","BK4137","LU0029874061.USD","LABU","BK4581","HCSG","CNDA","XLV","XBI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665937815","title":"Definium Therapeutics Gains FDA Breakthrough for Depression Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2665937815","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665937815?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:35","pubTimestamp":1788870934,"startTime":"0","endTime":"0","summary":"Definium Therapeutics ( ($DFTX) ) just unveiled an announcement. On September 8, 2026, Definium Therapeutics announced that the U.S. Food and Drug ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-gains-fda-breakthrough-for-depression-drug?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-gains-fda-breakthrough-for-depression-drug?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX","BK4007","LABU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665378198","title":"CRISPR Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2665378198","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665378198?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:30","pubTimestamp":1788870600,"startTime":"0","endTime":"0","summary":"ZUG, Switzerland and BOSTON, Sept.  08, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today announced that members of its senior management team will present at the Morgan Stanley 24th A","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/08/3357662/0/en/crispr-therapeutics-to-present-at-the-morgan-stanley-24th-annual-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","LU1861559042.SGD","BK4137","ARKG","SYNB","BK4139","BK4588","XLV","BK4556","BK4581","LU0128526141.USD","BK4585","CRSP","LU0029874061.USD","HCSG","LU1861558580.USD","LABU","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665320747","title":"Intellia Therapeutics announces FDA acceptance of lonvo-z BLA","url":"https://stock-news.laohu8.com/highlight/detail?id=2665320747","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665320747?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:11","pubTimestamp":1788869463,"startTime":"0","endTime":"0","summary":"Intellia Therapeutics (NTLA) announced the FDA has accepted the biologics license application for lonvo-z and granted the BLA Priority Review with ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/intellia-therapeutics-announces-fda-acceptance-of-lonvo-z-bla-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/intellia-therapeutics-announces-fda-acceptance-of-lonvo-z-bla-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1861559042.SGD","BK4139","BK4588","NTLA","BK4556","BK4585","BK4535","LU1861558580.USD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665320061","title":"Alebund Wins FDA IND Clearance for First-in-Class IgA Nephropathy Drug AP308","url":"https://stock-news.laohu8.com/highlight/detail?id=2665320061","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665320061?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:07","pubTimestamp":1788869273,"startTime":"0","endTime":"0","summary":"Alebund Pharmaceuticals (Jiangsu) Limited Class H ( ($HK:9637) ) has shared an update. Alebund Pharmaceuticals has secured clearance from the U.S. ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alebund-wins-fda-ind-clearance-for-first-in-class-iga-nephropathy-drug-ap308?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alebund-wins-fda-ind-clearance-for-first-in-class-iga-nephropathy-drug-ap308?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665327109","title":"NovaBridge Biosciences Strengthens Board with Appointment of Veteran Healthcare Executive","url":"https://stock-news.laohu8.com/highlight/detail?id=2665327109","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665327109?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:28","pubTimestamp":1788866923,"startTime":"0","endTime":"0","summary":"The latest announcement is out from NovaBridge Biosciences ( ($NBP) ). NovaBridge Biosciences reported on September 8, 2026, that it has appointed ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novabridge-biosciences-strengthens-board-with-appointment-of-veteran-healthcare-executive?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novabridge-biosciences-strengthens-board-with-appointment-of-veteran-healthcare-executive?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4581","LABU","LU0128526141.USD","LU0029874061.USD","NBP","BK4588","BK4585","XLV","HCSG","BK4137","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665387327","title":"Definium Therapeutics receives Breakthrough Therapy designation for DT120 ODT","url":"https://stock-news.laohu8.com/highlight/detail?id=2665387327","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665387327?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:11","pubTimestamp":1788865879,"startTime":"0","endTime":"0","summary":"Definium Therapeutics (DFTX) announced that the U.S. Food and Drug Administration, FDA, has granted Breakthrough Therapy designation for DT120 Oral...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-receives-breakthrough-therapy-designation-for-dt120-odt-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-receives-breakthrough-therapy-designation-for-dt120-odt-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","BK4585","BK4007","DFTX","ODT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665716322","title":"Atea Pharmaceuticals to Present at the Morgan Stanley 24th Annual Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2665716322","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665716322?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:00","pubTimestamp":1788865200,"startTime":"0","endTime":"0","summary":"BOSTON, Sept.  08, 2026 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a late-stage clinical biopharmaceutical company engaged in the discovery and development of ora","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/08/3357480/0/en/atea-pharmaceuticals-to-present-at-the-morgan-stanley-24th-annual-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0128526141.USD","LABU","BK4137","BK4585","HCSG","BK4007","LU0029874061.USD","XBI","XLV","BK4581","AVIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322718","title":"X4 Pharmaceuticals Announces Positive Outcome from FDA Type C Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322718","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322718?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:00","pubTimestamp":1788865200,"startTime":"0","endTime":"0","summary":"- FDA Agrees to Reduced Sample Size for the Global 4WARD Phase 3 Chronic Neutropenia Trial - - Expect Completion of Enrollment by Year-End 2026 and Topline Data in H1 2028 - BOSTON, Sept.  08, 2026 (G","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/08/3357473/0/en/x4-pharmaceuticals-announces-positive-outcome-from-fda-type-c-meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665232230","title":"Analysts Offer Insights on Healthcare Companies: Dyne Therapeutics (DYN), NewAmsterdam Pharma Company (NAMS) and Ionis Pharmaceuticals (IONS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665232230","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665232230?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:50","pubTimestamp":1788864614,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Dyne Therapeutics (DYN), NewAmsterdam Pharma Company...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-dyne-therapeutics-dyn-newamsterdam-pharma-company-nams-and-ionis-pharmaceuticals-ions-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-dyne-therapeutics-dyn-newamsterdam-pharma-company-nams-and-ionis-pharmaceuticals-ions-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IONS","XBI","XLV","BK4139","LU0128526141.USD","BK4588","NAMS","BK4505","HCSG","BK4585","BK4137","DYN","BK4581","LU0029874061.USD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322379","title":"Apitegromab’s Expanding FSHD Opportunity Supports Buy Rating; $65 Price Target Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322379","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322379?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:45","pubTimestamp":1788864320,"startTime":"0","endTime":"0","summary":"Scholar Rock Holding, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Andres Y. Maldonado from H.C. Wainwright...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/apitegromabs-expanding-fshd-opportunity-supports-buy-rating-65-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/apitegromabs-expanding-fshd-opportunity-supports-buy-rating-65-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","LABU","XLV","BK4581","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":5,"totalSize":412,"code":"91000000","status":"200"}]}}